Session 3 of Young Investigator Symposium
11 December 2024
A PVRI 2024 Digital webinar
11 December 2024, 3pm GMT
The Young Investigators Series aims to showcase the groundbreaking research being done by clinicians and scientists that are early in their careers. Sessions will be divided to focus on clinical research or basic science translational research. The PVRI Leadership has the goal to be inclusive, to support, and to highlight the work being done by individuals in the pulmonary vascular research field, including its newest and youngest members.
Presentations
- Hispanic ethnicity and social determinants of health in pulmonary arterial hypertension Roberto Bernardo, Indiana University School of Medicine
- Sirtuin 3 and uncoupling protein2, the missing link between genetics, metabolism, and pulmonary arterial hypertension Yongneng Zhang, University of Alberta
- Estrogen and portopulmonary hypertension: the Pulmonary Vascular Complications of Liver Disease Study Nadine Al-Naamani, University of Pennsylvania
- The right heart network and risk stratification in pulmonary arterial hypertension Andrew J Sweatt, Stanford University
- Cardiomyocyte-specific telomere shortening is a distinct signature of heart failure in humans
- Pulmonary hypertension caused by autocrine endothelial signaling Zhiyu Dai, Washington University in St. Louis
Moderated by Sebastien Bonnet, Laval University and James West, Vanderbilt University
Speakers & moderators
Roberto Bernardo, Indiana University School of Medicine, USA
Yongneng Zhang, University of Alberta, Canada
Nadine Al-Naamani, University of Pennsylvania, USA
Zhiyu Dai, Washington University in St. Louis, USA
Sebastien Bonnet, Laval University, Quebec City, Canada
James West, Vanderbilt University, USA
Andrew J Sweatt, , Stanford University, USA
Additional comments are available to members. Login or register to become a member today
RegisterorLogin to view